Murat M M Harputluoglu1, Ramazan Dertli2, Baris Otlu3, Ulvi Demirel4, Ozkan Yener3, Yilmaz Bilgic5, Mehmet Ali Erdogan5, Yahya Atayan5, Yasir Furkan Cagin5. 1. Department of Gastroenterology, Medical Faculty, Inonu University, Malatya, Turkey. mharputluoglu@hotmail.com. 2. Department of Internal Medicine, Medical Faculty, Inonu University, Malatya, Turkey. 3. Department of Microbiology, Medical Faculty, Inonu University, Malatya, Turkey. 4. Department of Gastroenterology, Medical Faculty, Firat University, Elazig, Turkey. 5. Department of Gastroenterology, Medical Faculty, Inonu University, Malatya, Turkey.
Abstract
BACKGROUND: The occurrence of spontaneous bacterial peritonitis (SBP) is significantly increased in carriers of nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants, suggesting that local immune alterations might be implicated in bacterial translocation (BT). AIMS: We aimed to assess the role of the NOD2 gene in conferring susceptibility to SBP. We also sought to determine whether levels of serum interleukin-6 (IL-6), lipopolysaccharide-binding protein, and soluble TNF-α receptor, along with the presence of bacterial DNA (bactDNA) in ascitic fluid, are appropriate markers for BT in patients with liver cirrhosis and SBP. METHODS: A cohort of 171 patients was divided into two groups: patients with SBP (n = 82) and those without SBP (n = 89). The presence of the most common NOD2 variants (p.R702W, p.G908R, and c.3020insC) was determined in these patients. RESULTS: We detected the p.G908R variant in four patients (4.9 %) of the SBP group. No significant difference was observed between the SBP and non-SBP groups for NOD2 risk variants. The frequency of bactDNA in ascitic fluid was higher for patients with NOD2 variants than for patients without variants (p = 0.021). Serum IL-6 levels in the SBP group were higher than those in the non-SBP group. CONCLUSIONS: The frequent detection of bactDNA in ascites of patients with the p.G908R variant suggests there is a strong association between NOD2 risk variants and BT in SBP patients. In addition, increased serum IL-6 levels and bactDNA in ascitic fluid could be considered surrogate markers for BT in patients with cirrhosis.
BACKGROUND: The occurrence of spontaneous bacterial peritonitis (SBP) is significantly increased in carriers of nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants, suggesting that local immune alterations might be implicated in bacterial translocation (BT). AIMS: We aimed to assess the role of the NOD2 gene in conferring susceptibility to SBP. We also sought to determine whether levels of serum interleukin-6 (IL-6), lipopolysaccharide-binding protein, and soluble TNF-α receptor, along with the presence of bacterial DNA (bactDNA) in ascitic fluid, are appropriate markers for BT in patients with liver cirrhosis and SBP. METHODS: A cohort of 171 patients was divided into two groups: patients with SBP (n = 82) and those without SBP (n = 89). The presence of the most common NOD2 variants (p.R702W, p.G908R, and c.3020insC) was determined in these patients. RESULTS: We detected the p.G908R variant in four patients (4.9 %) of the SBP group. No significant difference was observed between the SBP and non-SBP groups for NOD2 risk variants. The frequency of bactDNA in ascitic fluid was higher for patients with NOD2 variants than for patients without variants (p = 0.021). Serum IL-6 levels in the SBP group were higher than those in the non-SBP group. CONCLUSIONS: The frequent detection of bactDNA in ascites of patients with the p.G908R variant suggests there is a strong association between NOD2 risk variants and BT in SBP patients. In addition, increased serum IL-6 levels and bactDNA in ascitic fluid could be considered surrogate markers for BT in patients with cirrhosis.
Authors: Tony Bruns; Jack Peter; Philipp A Reuken; Dominik H Grabe; Sonja R Schuldes; Julia Brenmoehl; Jürgen Schölmerich; Reiner Wiest; Andreas Stallmach Journal: Liver Int Date: 2011-06-13 Impact factor: 5.828
Authors: Jean-Pierre Hugot; Isabelle Zaccaria; Juleen Cavanaugh; Huiying Yang; Séverine Vermeire; Maarit Lappalainen; Stefan Schreiber; Vito Annese; Derek P Jewell; Elizabeth V Fowler; Steven R Brant; Mark S Silverberg; Judy Cho; John D Rioux; Jack Satsangi; Miles Parkes Journal: Am J Gastroenterol Date: 2007-02-23 Impact factor: 10.864
Authors: Tony Bruns; Svea Sachse; Eberhard Straube; Sentayehu Assefa; Andreas Herrmann; Stefan Hagel; Marc Lehmann; Andreas Stallmach Journal: Liver Int Date: 2009-07-07 Impact factor: 5.828
Authors: Thomas Reiberger; Arnulf Ferlitsch; Berit A Payer; Mattias Mandorfer; Birgit B Heinisch; Hubert Hayden; Frank Lammert; Michael Trauner; Markus Peck-Radosavljevic; Harald Vogelsang Journal: J Hepatol Date: 2012-12-20 Impact factor: 25.083
Authors: Tony Bruns; Philipp A Reuken; Sven Stengel; Ludmila Gerber; Beate Appenrodt; Johannes H Schade; Frank Lammert; Stefan Zeuzem; Andreas Stallmach Journal: Dig Dis Sci Date: 2016-04-06 Impact factor: 3.199
Authors: Ramazan Dertli; Mehmet Asil; Murat Bıyık; Ahmet Karakarcayıldız; Muharrem Keskin; Yusuf Kayar; Müşerref Başdemirci; Hüseyin Ataseven Journal: Turk J Gastroenterol Date: 2021-07 Impact factor: 1.852
Authors: Martina Mai; Sven Stengel; Eihab Al-Herwi; Jack Peter; Caroline Schmidt; Ignacio Rubio; Andreas Stallmach; Tony Bruns Journal: Sci Rep Date: 2017-07-07 Impact factor: 4.379
Authors: Jelte J Schaapman; Àlex Amoros; Johan J van der Reijden; Wim Laleman; Stefan Zeuzem; Rafael Bañares; Rajiv Jalan; Vicente Arroyo; Joan Clària; Hein W Verspaget; Minneke J Coenraad Journal: Liver Int Date: 2020-02-16 Impact factor: 5.828
Authors: Matthias Christian Reichert; Cristina Ripoll; Markus Casper; Robin Greinert; Edith Vandieken; Frank Grünhage; Beate Appenrodt; Alexander Zipprich; Frank Lammert Journal: Clin Transl Gastroenterol Date: 2019-01 Impact factor: 4.488